The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tetanus Vaccine Market Research Report 2025
Synopsis
Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date on their tetanus immunization a booster should be given within 48 hours of an injury. In those with high risk injuries who are not fully immunized tetanus antitoxin may also be recommended. Making sure women who are pregnant are up to date on their tetanus immunization and, if not, immunizing them can prevent neonatal tetanus.
The vaccine is very safe including during pregnancy and in those with HIV/AIDS. Redness and pain at the site of injection occur in between 25% and 85% of people. Fever, feeling tired, and minor muscles pains occur in less than 10% of people. Severe allergic reactions occur in less than one in 100,000 people.
A number of vaccine combinations include the tetanus vaccine such as DTaP and Tdap which contain diphtheria, tetanus, and pertussis vaccine, and DT and Td which contain diphtheria and tetanus vaccine. DTaP and DT are given to children less than seven years old while Tdap and Td are given to those seven years old and older. The lowercase d and p denote lower strengths of diphtheria and pertussis vaccines.
The tetanus vaccine was developed in 1924 and became available in the United States in the 1940s. Its use resulted in a 95% decrease in the rate of tetanus. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.In the United States a course of tetanus vaccine is between 25 and 50 USD.
The global Tetanus Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tetanus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tetanus Vaccine.
Report Scope
The Tetanus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tetanus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tetanus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline plc
Pfizer,Inc
Merck & Co.,Inc
Sanofi Pasteur SA
Biological E
Dano Vaccine &Biological Pvt.Ltd.,
Panera
Shantha Biotechnics Ltd
Segment by Type
Diphtheria and tetanus (DT) vaccines
Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
Tetanus and diphtheria (Td) vaccines
Tetanus, diphtheria, and pertussis (Tdap) vaccines
Segment by Application
Adult
Pediatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tetanus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tetanus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date on their tetanus immunization a booster should be given within 48 hours of an injury. In those with high risk injuries who are not fully immunized tetanus antitoxin may also be recommended. Making sure women who are pregnant are up to date on their tetanus immunization and, if not, immunizing them can prevent neonatal tetanus.
The vaccine is very safe including during pregnancy and in those with HIV/AIDS. Redness and pain at the site of injection occur in between 25% and 85% of people. Fever, feeling tired, and minor muscles pains occur in less than 10% of people. Severe allergic reactions occur in less than one in 100,000 people.
A number of vaccine combinations include the tetanus vaccine such as DTaP and Tdap which contain diphtheria, tetanus, and pertussis vaccine, and DT and Td which contain diphtheria and tetanus vaccine. DTaP and DT are given to children less than seven years old while Tdap and Td are given to those seven years old and older. The lowercase d and p denote lower strengths of diphtheria and pertussis vaccines.
The tetanus vaccine was developed in 1924 and became available in the United States in the 1940s. Its use resulted in a 95% decrease in the rate of tetanus. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.In the United States a course of tetanus vaccine is between 25 and 50 USD.
The global Tetanus Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tetanus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tetanus Vaccine.
Report Scope
The Tetanus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tetanus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tetanus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline plc
Pfizer,Inc
Merck & Co.,Inc
Sanofi Pasteur SA
Biological E
Dano Vaccine &Biological Pvt.Ltd.,
Panera
Shantha Biotechnics Ltd
Segment by Type
Diphtheria and tetanus (DT) vaccines
Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
Tetanus and diphtheria (Td) vaccines
Tetanus, diphtheria, and pertussis (Tdap) vaccines
Segment by Application
Adult
Pediatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tetanus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tetanus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Tetanus Vaccine Market Overview
1.1 Product Overview and Scope of Tetanus Vaccine
1.2 Tetanus Vaccine Segment by Type
1.2.1 Global Tetanus Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Diphtheria and tetanus (DT) vaccines
1.2.3 Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
1.2.4 Tetanus and diphtheria (Td) vaccines
1.2.5 Tetanus, diphtheria, and pertussis (Tdap) vaccines
1.3 Tetanus Vaccine Segment by Application
1.3.1 Global Tetanus Vaccine Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Pediatric
1.4 Global Tetanus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Tetanus Vaccine Revenue 2019-2030
1.4.2 Global Tetanus Vaccine Sales 2019-2030
1.4.3 Global Tetanus Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tetanus Vaccine Market Competition by Manufacturers
2.1 Global Tetanus Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tetanus Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tetanus Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Tetanus Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tetanus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tetanus Vaccine, Product Type & Application
2.7 Tetanus Vaccine Market Competitive Situation and Trends
2.7.1 Tetanus Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tetanus Vaccine Players Market Share by Revenue
2.7.3 Global Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tetanus Vaccine Retrospective Market Scenario by Region
3.1 Global Tetanus Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tetanus Vaccine Global Tetanus Vaccine Sales by Region: 2019-2030
3.2.1 Global Tetanus Vaccine Sales by Region: 2019-2024
3.2.2 Global Tetanus Vaccine Sales by Region: 2025-2030
3.3 Global Tetanus Vaccine Global Tetanus Vaccine Revenue by Region: 2019-2030
3.3.1 Global Tetanus Vaccine Revenue by Region: 2019-2024
3.3.2 Global Tetanus Vaccine Revenue by Region: 2025-2030
3.4 North America Tetanus Vaccine Market Facts & Figures by Country
3.4.1 North America Tetanus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tetanus Vaccine Sales by Country (2019-2030)
3.4.3 North America Tetanus Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tetanus Vaccine Market Facts & Figures by Country
3.5.1 Europe Tetanus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tetanus Vaccine Sales by Country (2019-2030)
3.5.3 Europe Tetanus Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tetanus Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Tetanus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tetanus Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Tetanus Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tetanus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Tetanus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tetanus Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Tetanus Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tetanus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Tetanus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tetanus Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tetanus Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tetanus Vaccine Sales by Type (2019-2030)
4.1.1 Global Tetanus Vaccine Sales by Type (2019-2024)
4.1.2 Global Tetanus Vaccine Sales by Type (2025-2030)
4.1.3 Global Tetanus Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Tetanus Vaccine Revenue by Type (2019-2030)
4.2.1 Global Tetanus Vaccine Revenue by Type (2019-2024)
4.2.2 Global Tetanus Vaccine Revenue by Type (2025-2030)
4.2.3 Global Tetanus Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Tetanus Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tetanus Vaccine Sales by Application (2019-2030)
5.1.1 Global Tetanus Vaccine Sales by Application (2019-2024)
5.1.2 Global Tetanus Vaccine Sales by Application (2025-2030)
5.1.3 Global Tetanus Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Tetanus Vaccine Revenue by Application (2019-2030)
5.2.1 Global Tetanus Vaccine Revenue by Application (2019-2024)
5.2.2 Global Tetanus Vaccine Revenue by Application (2025-2030)
5.2.3 Global Tetanus Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Tetanus Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline plc
6.1.1 GlaxoSmithKline plc Corporation Information
6.1.2 GlaxoSmithKline plc Description and Business Overview
6.1.3 GlaxoSmithKline plc Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline plc Tetanus Vaccine Product Portfolio
6.1.5 GlaxoSmithKline plc Recent Developments/Updates
6.2 Pfizer,Inc
6.2.1 Pfizer,Inc Corporation Information
6.2.2 Pfizer,Inc Description and Business Overview
6.2.3 Pfizer,Inc Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer,Inc Tetanus Vaccine Product Portfolio
6.2.5 Pfizer,Inc Recent Developments/Updates
6.3 Merck & Co.,Inc
6.3.1 Merck & Co.,Inc Corporation Information
6.3.2 Merck & Co.,Inc Description and Business Overview
6.3.3 Merck & Co.,Inc Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck & Co.,Inc Tetanus Vaccine Product Portfolio
6.3.5 Merck & Co.,Inc Recent Developments/Updates
6.4 Sanofi Pasteur SA
6.4.1 Sanofi Pasteur SA Corporation Information
6.4.2 Sanofi Pasteur SA Description and Business Overview
6.4.3 Sanofi Pasteur SA Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Pasteur SA Tetanus Vaccine Product Portfolio
6.4.5 Sanofi Pasteur SA Recent Developments/Updates
6.5 Biological E
6.5.1 Biological E Corporation Information
6.5.2 Biological E Description and Business Overview
6.5.3 Biological E Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biological E Tetanus Vaccine Product Portfolio
6.5.5 Biological E Recent Developments/Updates
6.6 Dano Vaccine &Biological Pvt.Ltd.,
6.6.1 Dano Vaccine &Biological Pvt.Ltd., Corporation Information
6.6.2 Dano Vaccine &Biological Pvt.Ltd., Description and Business Overview
6.6.3 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Product Portfolio
6.6.5 Dano Vaccine &Biological Pvt.Ltd., Recent Developments/Updates
6.7 Panera
6.6.1 Panera Corporation Information
6.6.2 Panera Description and Business Overview
6.6.3 Panera Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Panera Tetanus Vaccine Product Portfolio
6.7.5 Panera Recent Developments/Updates
6.8 Shantha Biotechnics Ltd
6.8.1 Shantha Biotechnics Ltd Corporation Information
6.8.2 Shantha Biotechnics Ltd Description and Business Overview
6.8.3 Shantha Biotechnics Ltd Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shantha Biotechnics Ltd Tetanus Vaccine Product Portfolio
6.8.5 Shantha Biotechnics Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tetanus Vaccine Industry Chain Analysis
7.2 Tetanus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tetanus Vaccine Production Mode & Process
7.4 Tetanus Vaccine Sales and Marketing
7.4.1 Tetanus Vaccine Sales Channels
7.4.2 Tetanus Vaccine Distributors
7.5 Tetanus Vaccine Customers
8 Tetanus Vaccine Market Dynamics
8.1 Tetanus Vaccine Industry Trends
8.2 Tetanus Vaccine Market Drivers
8.3 Tetanus Vaccine Market Challenges
8.4 Tetanus Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Tetanus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Tetanus Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Tetanus Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Tetanus Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Tetanus Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Tetanus Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Tetanus Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Tetanus Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Tetanus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tetanus Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tetanus Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Tetanus Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tetanus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tetanus Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tetanus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Tetanus Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Tetanus Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Tetanus Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Tetanus Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Tetanus Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Tetanus Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Tetanus Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Tetanus Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Tetanus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Tetanus Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Tetanus Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Tetanus Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Tetanus Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Tetanus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Tetanus Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Tetanus Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Tetanus Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Tetanus Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Tetanus Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Tetanus Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Tetanus Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Tetanus Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Tetanus Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tetanus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Tetanus Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Tetanus Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Tetanus Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Tetanus Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Tetanus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Tetanus Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Tetanus Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Tetanus Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Tetanus Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Tetanus Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Tetanus Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Tetanus Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Tetanus Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Tetanus Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Tetanus Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Tetanus Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Tetanus Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Tetanus Vaccine Price (USD/Unit) by Type (2019-2024)
Table 59. Global Tetanus Vaccine Price (USD/Unit) by Type (2025-2030)
Table 60. Global Tetanus Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Tetanus Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Tetanus Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Tetanus Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Tetanus Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Tetanus Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Tetanus Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Tetanus Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Tetanus Vaccine Price (USD/Unit) by Application (2019-2024)
Table 69. Global Tetanus Vaccine Price (USD/Unit) by Application (2025-2030)
Table 70. GlaxoSmithKline plc Corporation Information
Table 71. GlaxoSmithKline plc Description and Business Overview
Table 72. GlaxoSmithKline plc Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. GlaxoSmithKline plc Tetanus Vaccine Product
Table 74. GlaxoSmithKline plc Recent Developments/Updates
Table 75. Pfizer,Inc Corporation Information
Table 76. Pfizer,Inc Description and Business Overview
Table 77. Pfizer,Inc Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer,Inc Tetanus Vaccine Product
Table 79. Pfizer,Inc Recent Developments/Updates
Table 80. Merck & Co.,Inc Corporation Information
Table 81. Merck & Co.,Inc Description and Business Overview
Table 82. Merck & Co.,Inc Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Merck & Co.,Inc Tetanus Vaccine Product
Table 84. Merck & Co.,Inc Recent Developments/Updates
Table 85. Sanofi Pasteur SA Corporation Information
Table 86. Sanofi Pasteur SA Description and Business Overview
Table 87. Sanofi Pasteur SA Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sanofi Pasteur SA Tetanus Vaccine Product
Table 89. Sanofi Pasteur SA Recent Developments/Updates
Table 90. Biological E Corporation Information
Table 91. Biological E Description and Business Overview
Table 92. Biological E Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Biological E Tetanus Vaccine Product
Table 94. Biological E Recent Developments/Updates
Table 95. Dano Vaccine &Biological Pvt.Ltd., Corporation Information
Table 96. Dano Vaccine &Biological Pvt.Ltd., Description and Business Overview
Table 97. Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Product
Table 99. Dano Vaccine &Biological Pvt.Ltd., Recent Developments/Updates
Table 100. Panera Corporation Information
Table 101. Panera Description and Business Overview
Table 102. Panera Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Panera Tetanus Vaccine Product
Table 104. Panera Recent Developments/Updates
Table 105. Shantha Biotechnics Ltd Corporation Information
Table 106. Shantha Biotechnics Ltd Description and Business Overview
Table 107. Shantha Biotechnics Ltd Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Shantha Biotechnics Ltd Tetanus Vaccine Product
Table 109. Shantha Biotechnics Ltd Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Tetanus Vaccine Distributors List
Table 113. Tetanus Vaccine Customers List
Table 114. Tetanus Vaccine Market Trends
Table 115. Tetanus Vaccine Market Drivers
Table 116. Tetanus Vaccine Market Challenges
Table 117. Tetanus Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tetanus Vaccine
Figure 2. Global Tetanus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Tetanus Vaccine Market Share by Type in 2023 & 2030
Figure 4. Diphtheria and tetanus (DT) vaccines Product Picture
Figure 5. Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines Product Picture
Figure 6. Tetanus and diphtheria (Td) vaccines Product Picture
Figure 7. Tetanus, diphtheria, and pertussis (Tdap) vaccines Product Picture
Figure 8. Global Tetanus Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Tetanus Vaccine Market Share by Application in 2023 & 2030
Figure 10. Adult
Figure 11. Pediatric
Figure 12. Global Tetanus Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Tetanus Vaccine Market Size (2019-2030) & (US$ Million)
Figure 14. Global Tetanus Vaccine Sales (2019-2030) & (K Units)
Figure 15. Global Tetanus Vaccine Average Price (USD/Unit) & (2019-2030)
Figure 16. Tetanus Vaccine Report Years Considered
Figure 17. Tetanus Vaccine Sales Share by Manufacturers in 2023
Figure 18. Global Tetanus Vaccine Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Tetanus Vaccine Players: Market Share by Revenue in 2023
Figure 20. Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Tetanus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Tetanus Vaccine Sales Market Share by Country (2019-2030)
Figure 23. North America Tetanus Vaccine Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Tetanus Vaccine Sales Market Share by Country (2019-2030)
Figure 27. Europe Tetanus Vaccine Revenue Market Share by Country (2019-2030)
Figure 28. Germany Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Tetanus Vaccine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Tetanus Vaccine Revenue Market Share by Region (2019-2030)
Figure 35. China Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Tetanus Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Latin America Tetanus Vaccine Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Tetanus Vaccine Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Tetanus Vaccine Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Tetanus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Tetanus Vaccine by Type (2019-2030)
Figure 56. Global Revenue Market Share of Tetanus Vaccine by Type (2019-2030)
Figure 57. Global Tetanus Vaccine Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Tetanus Vaccine by Application (2019-2030)
Figure 59. Global Revenue Market Share of Tetanus Vaccine by Application (2019-2030)
Figure 60. Global Tetanus Vaccine Price (USD/Unit) by Application (2019-2030)
Figure 61. Tetanus Vaccine Value Chain
Figure 62. Tetanus Vaccine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
